Nouscom competitorsClear all

Nouscom's top competitors include Orchard Therapeutics and Talaris Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Nouscom
Nouscom
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Orchard Therapeutics
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
Talaris Therapeutics
Talaris Therapeutics
Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation.
Founding Date
Founding Date
2015
Founding Date
2015
Founding Date
2002
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Basel, CH HQ
Roma, IT
Locations
London, GB HQ
Boston, US
Boston, US
Foster City, US
Menlo Park, US
Locations
Louisville, US HQ
Louisville, US
Wellesley, US
Employees
Employees
35
Employees
252
Employees
82
Valuation ($)
Valuation ($)
N/A
Valuation ($)
218.1 m
Valuation ($)
660.7 m
Alexa Website Rank
Alexa Website Rank
245902
Alexa Website Rank
281582
Alexa Website Rank
291029
Employee Rating
Employee Rating
3.5
Employee Rating
3.8
Employee Rating
4.3

Funding

Total funding raised
Total funding raised
$ 62.6m
Total funding raised
$ 310.7m
Total funding raised
$ 215m
For sources of this data, please see the company profile

View company profiles

Orchard Therapeutics
HQ
London, GB
Employees
252

Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.

View company
Talaris Therapeutics
HQ
Louisville, US
Employees
82

Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation.

View company